Table of Contents Author Guidelines Submit a Manuscript
Evidence-based Complementary and Alternative Medicine
Volume 2011, Article ID 391752, 10 pages
http://dx.doi.org/10.1093/ecam/nen090
Original Article

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide

1Department of Zoology, University of Kalyani, Kalyani-741235, India
2Boiron Lab, 69110 Sainte-Foy-Les-Lyon, France

Received 4 January 2008; Accepted 19 December 2008

Copyright © 2011 Pathikrit Banerjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. García-Chávez, A. Santamaría, F. Díaz-Barriga, P. Mandeville, B. I. Juárez, and M. E. Jiménez-Capdeville, “Arsenite-induced formation of hydroxyl radical in the striatum of awake rats,” Brain Research, vol. 976, no. 1, pp. 82–89, 2003. View at Publisher · View at Google Scholar
  2. J. Pi, H. Yamauchi, Y. Kumagai et al., “Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water,” Environmental Health Perspectives, vol. 110, no. 4, pp. 331–336, 2002. View at Google Scholar
  3. S. Ahmad, K. T. Kitchin, and W. R. Cullen, “Arsenic species that cause release of iron from ferritin and generation of activated oxygen,” Archives of Biochemistry and Biophysics, vol. 382, no. 2, pp. 195–202, 2000. View at Publisher · View at Google Scholar · View at PubMed
  4. H. U. Bergmeyer and E. Brent, “Aminotransferases,” in Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 735–760, Verlag Chemie Weinheim. Academic Press, New York, NY, USA, 1974. View at Google Scholar
  5. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Google Scholar
  6. B. Chance and A. C. Maehly, “Assay of catalase and peroxidase,” Methods in Enzymol, vol. 2, pp. 764–775, 1955. View at Google Scholar
  7. P. Kakkar, B. Das, and P. N. Viswanathan, “A modified spectrophotometric assay of superoxide dismutase,” Indian Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130–132, 1984. View at Google Scholar
  8. E. C. Slater and W. D. Bonner, “The effect of fluoride on succinic oxidase system,” Biochemical Journal, vol. 52, pp. 185–196, 1952. View at Google Scholar
  9. I. Carlberg and B. Mannervik, “Glutathione reductase levels in rat brain,” The Journal of Biological Chemistry, vol. 250, no. 14, pp. 5475–5480, 1975. View at Google Scholar
  10. J. Mohandas, J. J. Marshall, G. G. Duggin, J. S. Horvath, and D. Tiller, “Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: possible interactions in analgesic neuropathy,” Cancer Research, vol. 44, pp. 5086–5091, 1984. View at Google Scholar
  11. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with Folin-Phenol reagent,” The Journal of Biological Chemistry, vol. 193, pp. 265–275, 1951. View at Google Scholar
  12. S. Pathak and A. R. Khuda-Bukhsh, “Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethylaminoazobenzene and phenobarbital,” Experimental and Molecular Pathology, vol. 83, pp. 104–111, 2007. View at Google Scholar
  13. P. C. Billings, J. M. Habres, D. C. Liao, and S. W. Tuttle, “Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor,” Cancer Research, vol. 51, no. 20, pp. 5539–5543, 1991. View at Google Scholar
  14. R. A. Fisher and F. Yates, Statistical Tables for Biological, Agricultural and Medical Research, Oliver and Boyd, Edinburgh, UK, 6th edition, 1963.
  15. P.-Z. Zheng, K.-K. Wang, Q.-Y. Zhang et al., “Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation apoptosis of promyelocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 21, pp. 7653–7658, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. L. F. Zhou, Y. Zhu, X. F. Cui, W. P. Xie, A. H. Hu, and K. S. Yin, “Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation,” Respiratory Research, vol. 7, p. 146, 2006. View at Google Scholar
  17. S. Karasaki, “Cell proliferation and subcellular localization of alkaline phosphatase activity in rat liver parenchyma during azo dye induced carcinogenesis,” Cancer Research, vol. 35, pp. 482–491, 1975. View at Google Scholar
  18. R. O. Recknagel, E. A. Glende, and R. S. Britton, “Free radical damage and lipid peroxidation,” in Hepatotoxicology, R. G. Meeks, S. D. Harrison, and R. J. Bull, Eds., pp. 401–436, CRC Press, Boca Raton, Fla, USA, 1991. View at Google Scholar
  19. P. K. Eagon, N. Chandar, M. J. Epley, M. S. Elm, E. P. Brady, and K. N. Rao, “Di(2-ethylhexyl)phthalate-induced changes in liver estrogen metabolism and hyperplasia,” International Journal of Cancer, vol. 58, no. 5, pp. 736–743, 1994. View at Google Scholar
  20. M. J. Heslin, J. Yan, M. R. Johnson, H. Weiss, R. B. Diasio, and M. M. Urist, “Role of matrix metalloproteinases in colorectal carcinogenesis,” Annals of Surgery, vol. 233, no. 6, pp. 786–792, 2001. View at Publisher · View at Google Scholar
  21. L. A. Liotta, P. S. Steeg, and W. G. Stetler-Stevenson, “Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation,” Cell, vol. 64, no. 2, pp. 327–336, 1991. View at Google Scholar
  22. L. M. Matrisian, “Metalloproteinases and their inhibitors in matrix remodeling (Review),” Trends in Genetics, vol. 6, pp. 121–125, 1990. View at Google Scholar
  23. J. F. Woessner Jr., “Matrix metalloproteinases and their inhibitors in connective tissue remodeling,” The FASEB Journal, vol. 5, no. 8, pp. 2145–2154, 1991. View at Google Scholar
  24. A. Y. Lee, K. T. Akers, M. Collier, L. Li, A. Z. Eisen, and J. L. Seltzer, “Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4424–4429, 1997. View at Publisher · View at Google Scholar
  25. J. L. Seltzer, A. Y. Lee, K. Y. Akers, and M. Collier, “Activation of 72- kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction,” Experimental Cell Research, vol. 213, pp. 365–374, 1994. View at Google Scholar
  26. H. Birkedal-Hansen, “Proteolytic remodeling of extracellular matrix,” Current Opinion in Cell Biology, vol. 7, no. 5, pp. 728–735, 1995. View at Publisher · View at Google Scholar
  27. J. M. Ray and W. G. Stetler-Stevenson, “The role of matrix metalloproteases and their inhibitors in tissue invasion, metastasis and angiogenesis,” The European Respiratory Journal, vol. 7, pp. 2062–2072, 1994. View at Google Scholar
  28. Z. Wang, R. Juttermann, and P. D. Soloway, “TIMP-2 is required for efficient activation of proMMP-2 in vivo,” The Journal of Biological Chemistry, vol. 275, no. 34, pp. 26411–26415, 2000. View at Publisher · View at Google Scholar · View at PubMed
  29. A. R. Khuda-Bukhsh, “Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action in vivo,” Complementary Therapies in Medicine, vol. 5, pp. 43–46, 1997. View at Google Scholar
  30. A. R. Khuda-Bukhsh, “Towards understanding molecular mechanisms of action of homeopathic drugs: an overview,” Molecular and Cellular Biochemistry, vol. 253, no. 1-2, pp. 339–345, 2003. View at Publisher · View at Google Scholar
  31. A. R. Khuda-Bukhsh, J. R. Moffett, P. Arun, and M. A. A. Namboodiri, “Laboratory research in homeopathy: pro,” Integrative Cancer Therapies, vol. 5, no. 4, pp. 320–342, 2006. View at Publisher · View at Google Scholar · View at PubMed
  32. A. R. Khuda-Bukhsh and S. Pathak, “Homeopathic drug discovery: theory update and methodological aspect,” Expert Opinion on Drug Discovery, vol. 3, no. 8, pp. 979–990, 2008. View at Publisher · View at Google Scholar